Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.0K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.0K
Dementia01:30

Dementia

633
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
633
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

776
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
776
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Language and Cognition01:27

Language and Cognition

912
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
912

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opioid use disorder and dementia risk: evidence from observational and genetic analyses in diverse ancestry cohorts.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Cognition and future depression: associations with risk in those with and without a history of depression.

BMJ mental health·2026
Same author

Women and psychosis: a guide to evidence-based, hormone-informed care.

The lancet. Psychiatry·2026
Same author

Will Precision Medicine Still Require Neuropsychiatric Phenotypes?

Neurology·2026
Same author

Cannabis use, cognitive function and dementia risk in older adults: observational and genetic analyses.

BMJ mental health·2026
Same author

The Relationship Between Hippocampal Cerebrovascular Reactivity and Brain Structure in Older Age.

Human brain mapping·2026

Related Experiment Video

Updated: Mar 9, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.9K

Diagnosing early cognitive decline-When, how and for whom?

Charlotte L Allan1, Sophie Behrman2, Klaus P Ebmeier2

  • 1Centre for the Health of the Elderly, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle, UK.

Maturitas
|January 3, 2017
PubMed
Summary

Mild cognitive impairment (MCI) involves noticeable cognitive decline beyond normal aging, but not dementia. This review covers diagnosis, treatments, and legal issues for individuals experiencing early cognitive changes.

Keywords:
AssessmentDementiaDrivingMild cognitive impairmentNeuroimagingNeuropsychologyTreatment

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.0K

Related Experiment Videos

Last Updated: Mar 9, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.9K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.0K

Area of Science:

  • Neurology
  • Geriatrics
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) signifies cognitive deficits exceeding age-expected changes, distinct from dementia.
  • Early identification of cognitive decline is crucial for timely intervention and management.
  • Understanding MCI is vital for addressing the growing needs of an aging global population.

Purpose of the Study:

  • To review diagnostic approaches for early cognitive decline, specifically mild cognitive impairment (MCI).
  • To explore available treatments and support systems for individuals with MCI.
  • To outline medico-legal considerations relevant to cognitive impairment.

Main Methods:

  • Review of current literature on mild cognitive impairment (MCI) diagnosis.
  • Analysis of neuropsychological tests and neuroimaging techniques for cognitive assessment.
  • Examination of treatment strategies and medico-legal implications.

Main Results:

  • Neuropsychological tests and neuroimaging are key tools for diagnosing MCI.
  • Differential diagnosis is essential to distinguish MCI from other conditions.
  • A range of treatments, including prevention and support, can be offered.
  • Medico-legal aspects impact daily life, including driving and employment.

Conclusions:

  • Accurate diagnosis of mild cognitive impairment (MCI) relies on comprehensive assessment.
  • Early intervention and ongoing support are vital for managing MCI.
  • Addressing medico-legal issues is a critical component of comprehensive MCI care.